Peri-implant Vitamin D and Cathelicidin (LL-37) Levels

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
Peri-Implantitis and Peri-implant Mucositis
Interventions
DIAGNOSTIC_TEST

The patients' periodontal clinical parameters were recorded. PISF samples were collected, and the evaluations of 25(OH)D and LL-37 were conducted using enzyme-linked immunosorbent assay.

In vitro studies have shown that vitamin D promotes the release of antimicrobial peptides from gingival epithelial cells, no clinical research has specifically examined its effect on LL-37 levels in peri-implant tissue diseases. This study seeks to investigate the relationship between vitamin D levels in peri-implant sulcus fluid and clinical parameters in individuals with both peri-implant health and disease. Additionally, it aims to assess the correlation between vitamin D and the antimicrobial peptide LL-37.

Trial Locations (1)

34147

Altinbas University, Istanbul

All Listed Sponsors
lead

Altinbas University

OTHER

NCT06867250 - Peri-implant Vitamin D and Cathelicidin (LL-37) Levels | Biotech Hunter | Biotech Hunter